Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
17.84
+0.46 (2.68%)
Sep 23, 2025, 1:03 PM EDT - Market open
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $2.14 billion as of September 23, 2025. Its market cap has increased by 68.98% in one year.
Market Cap
2.14B
Enterprise Value
2.05B
1-Year Change
68.98%
Ranking
Category
Stock Price
$17.84
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $2.14B, an increase of 173.53%. That is a compound annual growth rate of 19.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2025 | 2.08B | 27.78% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | 1.23B | 56.71% |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.09B |
| Johnson & Johnson | 424.33B |
| AbbVie | 393.01B |
| UnitedHealth Group | 304.93B |
| Novo Nordisk | 271.64B |
| Novartis AG | 237.99B |
| Abbott Laboratories | 236.77B |
| AstraZeneca | 236.24B |